Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • ‘A Cup of Coffee a Day Keeps Dyskinesia Away?’

    Higher Caffeine Linked to Lower Parkinson’s in LRRK2 Mutation Carriers

    Recent research links higher caffeine in the blood samples and diets of people with a LRRK2 genetic mutation, which increases PD risk, with lower Parkinson’s.
    Learn more
  • Genetic testing

    MJFF and Northwestern Partner on Clinical Genetic Testing Series

    The Michael J. Fox Foundation and Northwestern University are co-sponsoring a new two-part educational course, Clinical Genetic Testing for Parkinson’s Disease: Why, When and How? A Virtual CME…
    Learn more
  • Lab Tubes

    Roche Buys MJFF-Grantee Inflazome in Deal to Develop Drugs against Inflammation

    Funding from The Michael J. Fox Foundation advanced biotech Inflazome’s therapeutic portfolio; the deal with Roche brings resources to move further in clinical testing.
    Learn more
  • Positive Results from Parkinson's LRRK2 Drug Trial

    New Therapy for Parkinson’s “Off” Time Reaches FDA

    A continuous apomorphine infusion, which aims to treat significant “off” time not controlled with oral PD meds, is now with the FDA for review.
    Learn more
  • ASAP logo and Scherzer team

    What We Fund: $161 Million to ASAP Initiative Teams

    The Aligning Science Across Parkinson’s (ASAP) initiative is funding 21 multidisciplinary teams investigating the biology of Parkinson’s genes or neuro-immune interactions.
    Learn more
  • Person smiling at camera.

    Fox DEN in Practice: Researcher Lands Top Abstract Recognition at Parkinson’s Congress

    We spoke with Meredith Bock, MD, to learn how she used the Fox DEN platform and landed top abstract designation at the International Parkinson and Movement Disorder Society Congress.
    Learn more
  • MDS Virtual Congress 2020 photo

    MJFF’s Guide to the International Congress of Parkinson's Disease and Movement Disorders

    Each year, the Congress brings together thousands of clinicians, researchers and members of industry working on movement disorders such as Parkinson’s.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.